Prothena (PRTA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

PRTA Prothena

Watchlist

14.550
-0.080-0.55%

Close Feb 26 16:00 ET

782.79MMarket Cap-6.41P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

CrowdStrike To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga14:03 ET
Prothena Is Maintained at Overweight by Piper Sandler
Dow Jones13:11 ET · Ratings
Piper Sandler Maintains Prothena(PRTA.US) With Buy Rating, Raises Target Price to $110
Moomoo NewsFeb 26 08:35 ET · Ratings
Prothena Price Target Raised to $110 From $94 at Piper Sandler
TipRanksFeb 26 07:46 ET
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
BenzingaFeb 24 08:00 ET
Analysts Are Bullish on Top Healthcare Stocks: Prothena (PRTA), Dexcom (DXCM)
TipRanksFeb 23 10:20 ET · Ratings

Comments

Jaguar8

Dec 19, 2024 10:16

Missed primary endpoint but went up 😂

$Prothena (PRTA.US)$

Moomoo AI

Jan 31, 2024 05:38

Investors may miss opportunities or face setbacks if there's no rational basis for the P/S ratio. The moderate P/S ratio suggests investors anticipate a slowdown in revenue. Many investors, less bearish than analysts, hold onto their stocks, risking future disappointment if P/S aligns with growth outlook.

What Prothena Corporation Plc's (NASDAQ:PRTA) P/S Is Not Telling You

Moomoo AI

Nov 28, 2023 05:12

Analysts are forecasting that Prothena will reach break-even point before it might exhaust its cash runway. Given its impressive revenue growth and reduction in cash burn, Prothena appears well positioned to fund further growth with minimal shareholder dilution or borrowing.

We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Moomoo AI

Oct 30, 2023 07:14

Despite recent declines, the company's strong growth signals a potential investment opportunity. Market response to its revenue growth indicates interest despite lack of profits.

Prothena (NASDAQ:PRTA) Shareholders Are Still up 224% Over 3 Years Despite Pulling Back 15% in the Past Week

Moomoo AI

Oct 9, 2023 08:34

Overvaluation risk looms for Prothena's shares with high P/S ratio amid poor revenue and weak growth forecast. Investors may face disappointment if the share price realigns with the firm's bleak future outlook.

Prothena Corporation Plc's (NASDAQ:PRTA) Price Is Out Of Tune With Revenues

PRTA Prothena

Trade Overview

Capital Trend

News

Comments

Trending Stocks